Motus GI Holdings Net Worth 2016-2024 | MOTS

Interactive chart of historical net worth (market cap) for Motus GI Holdings (MOTS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Motus GI Holdings net worth as of July 23, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.738B 59.46
Hims & Hers Health (HIMS) United States $12.987B 134.93
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $11.228B 0.00
IRhythm Technologies (IRTC) United States $4.298B 0.00
Inspire Medical Systems (INSP) United States $3.880B 60.62
Hinge Health (HNGE) United States $3.671B 0.00
Privia Health (PRVA) United States $2.475B 169.17
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.690B 0.00
10x Genomics (TXG) United States $1.677B 0.00
Phreesia (PHR) United States $1.648B 0.00
Enovis (ENOV) United States $1.582B 8.82
Azenta (AZTA) United States $1.578B 73.36
Omnicell (OMCL) United States $1.321B 23.31
Evolent Health (EVH) United States $1.199B 102.10
Claritev (CTEV) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.575B 0.00
Standard BioTools (LAB) United States $0.551B 0.00
Butterfly Network (BFLY) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Talkspace (TALK) United States $0.438B 131.00
TruBridge (TBRG) United States $0.347B 770.33
Outset Medical (OM) United States $0.345B 0.00
Health Catalyst (HCAT) United States $0.282B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.197B 0.00
Zepp Health (ZEPP) Netherlands $0.176B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.134B 0.00
MDxHealth SA (MDXH) Belgium $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.105B 3.98
Insight Molecular Diagnostics (IMDX) United States $0.086B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00